Dementia Associated with Alzheimer’s Disease Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Global Dementia Associated with Alzheimer’s Disease Market is estimated to value over USD 6.5 billion by 2026 end and register a CAGR of over 4.3% during the forecast period 2019 to 2026.
Research has
demonstrated that the aging population will not show signs of reduction as
there are disproportionate fertility rates and a rise in life expectancy. This
fluctuation towards the aging population is projected to play a role in the
high presence of Alzheimer’s disease which, in turn, will cause a significant
burden on health care systems, social care systems and humans alike, on a
global scale. Market study predicts that the surge in Alzheimer’s related
incidences is projected to augment the demand for improved therapies and
innovative drugs.
Within the geriatric
population, Alzheimer’s disease (AD) is a major cause for dementia. This, in
turn, will lead to a great deal of dependency on other people in the later part
of their lives. It is noteworthy that the treatment which is available can only
provide aid in the symptoms but there is no known cure for it. The medication
that is available cannot be easily acquired and several patients are left with
no choice but to suffer without any relief. Hence, there is a dire need for
alternative treatments that is both innovative and effective. But fierce
competition within the market for common drugs may hamper the global dementia
associated with Alzheimer’s disease market growth.
Programs in AD drug
development undergo stringent regulations and sanctions. If such a program
needs to be conducted, it will have to undertake a period of 13 years from the
time of preclinical studies till the time that it gets sanctioned by the FDA. Furthermore,
the treatment for altering the effects of Alzheimer’s disease requires many
strides and developments but subsequently, encounters many constraints. Such
constraints range from insufficient surrogate markers, challenges in selecting
ideal groups for clinical trials, as well as the sheer scale and length of time
required to conduct such trials. Such factors can negatively affect the global
dementia associated with Alzheimer’s disease market size
Among the foremost
companies which undertake certain efforts and measures in formulating
innovative drug program is the Japanese company known as Ono Pharmaceutical Co.
Ltd. They have acquired further approval for the formulation which contains new
ingredients which are known as Exelon and Rivastach Patches. Both of these
ingredients count as transdermal patches which subdues the penetration of
indications linked with mild to moderate dementia attributed to Alzheimer’s
Key
players who dominate this market includes Ono Pharmaceutical Co., Eisai Co.,
Ltd., Johnson & Johnson Services, Inc., Novartis AG, Allergan plc., Merz
Pharma GmbH & Co. KGaA., F. Hoffmann-La Roche Ltd, Daiichi Sankyo Company,
Pfizer, Inc., Limited, Ltd, H. Lundbeck A/S.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3488&page=requestsample
Global Dementia Associated with Alzheimer’s Disease
Market Segmentation:
By
Drug Class
- Cholinergic/
Cholinesterase (ChE) Inhibitors
- Donepezil
- Galantamine
- Rivastigmine
- Memantine
- Combined Drug
(Memantine & Donepezil) and Others
By
Distribution Channel
- Hospital Pharmacies
- Retail
- Online Sales
By
Region
- Europe
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase
a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3488&page=askfordiscount
FutureWise Key
Takeaways:
- Growth prospects
- SWOT analysis
- Key trends
- Key data-points affecting market growth
Objectives
of the Study:
- To provide with an exhaustive analysis on the
global dementia associated with Alzheimer’s disease market by drug class,
by distribution channel, and by region
- To cater comprehensive information on factors
impacting market growth (drivers, restraints, opportunities, and
industry-specific restraints)
- To evaluate and forecast micro-markets and the
overall market
- To predict the market size, in key regions (along
with countries)— North America, Europe, Asia Pacific, Latin America and
Middle East & Africa
- To record evaluate and competitive landscape
mapping- product launches, technological advancements, mergers and
expansions
We
specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the
forefront of their industry – a position secured for far more than the near
future.
Contact Us:
Company
Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Comments
Post a Comment